The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

AGM Statement

17 Nov 2015 07:00

RNS Number : 9153F
Craneware plc
17 November 2015
 

 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement

 

17 November 2015 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 9am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We have experienced a positive start to trading in the first few months of the year. In June, we launched the Value Cycle, our vision for the process and culture by which healthcare providers pursue quality patient outcomes and optimal financial performance within a healthcare market moving towards value-based care. Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.

 

This positive impact of the Value Cycle on the level of sales activity combined with the contribution of the prior year's sales flowing through to the current year financial results and the continued high levels of cash generation, mean we are well positioned to continue to execute on our growth strategy."

 

Craneware will be hosting an analyst and investor presentation at 11am today. The presentation to be given at the meeting will cover topics including the evolution of the US healthcare market towards value-based care, the escalation of patient engagement and consumerism, and the Value Cycle. The presentation will contain no new material information.

 

Copies of the presentation will be made available on the Company's website at www.craneware.com.

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)7515 805 218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Richard Kauffer

Hilary Buchanan

About Craneware

 

Craneware is the leader in automated value cycle solutions that help US provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston, Nashville and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCBDBUGBBGUL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.